Loading company…
PrimeLink develops antibody-drug conjugates and drug delivery systems.
Founded in 2021 and based in Shenzhen, China, PrimeLink conducts research and development in medical services, drug delivery systems, and antibody-drug conjugates (ADCs). Its research center is in Suzhou Industrial Park, and more than half of its core research team has a doctoral degree. The company was founded by Dr. Yin, who has nearly 20 years of ADC development experience. PrimeLink is building an ADC drug platform and product pipeline.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in